MET and Miyoshi myopathy: Using the same HR-MM model both in vitro and in vivo, Umezu demonstrated that miR-340 from healthy BMSC exosomes inhibited angiogenesis via the hepatocyte growth factor/c-MET (HGF/c-MET) signaling pathway in endothelial cells.